Scientists Identify Key Protein That Could Restore Brain Cell Regeneration With Age
A groundbreaking study reveals a potential pathway to reversing age-related cognitive decline by restoring the brain’s ability to create new cells. Researchers at the Yong Loo Lin School of Medicine at the National University of Singapore have pinpointed a protein, cyclin D-binding myb-like transcription factor 1 (DMTF1), as a central regulator of neural stem cell activity in aging brains, offering a promising target for future therapies.
The findings, published in Science Advances, represent a significant step forward in understanding the biological mechanisms behind age-related cognitive impairment. As we age, neural stem cells – responsible for generating new neurons crucial for learning and memory – gradually lose their regenerative capacity. This decline contributes directly to cognitive decline, but the underlying causes have remained elusive.
Uncovering the Role of DMTF1 in Aging Brains
The research team, led by Assistant Professor Ong Sek Tong Derrick, with Dr. Liang Yajing as first author, embarked on a mission to identify the specific biological changes that weaken neural stem cells over time. Their investigation focused on transcription factors, proteins that control gene expression, and their role in maintaining stem cell function.
To understand how DMTF1 functions, the researchers analyzed neural stem cells from both human sources and laboratory models mimicking premature aging. Utilizing advanced genome binding and transcriptome analyses, they mapped the protein’s influence on gene activity, with a particular emphasis on its interaction with cells experiencing telomere dysfunction. Telomeres, the protective caps on the ends of chromosomes, shorten with each cell division – a well-established marker of aging.
Restoring Regeneration: DMTF1 as a Therapeutic Target
The team’s experiments revealed a striking correlation: levels of DMTF1 were significantly reduced in “aged” neural stem cells. Critically, when DMTF1 expression was restored, the cells regained their ability to regenerate. This suggests that boosting DMTF1 levels could be a viable strategy for restoring stem cell function in the aging brain.
Further analysis illuminated how DMTF1 exerts its effects. The protein regulates “helper genes” – Arid2 and Ss18 – that loosen tightly packed DNA, enabling the activation of growth-related genes. Without these helper genes, neural stem cells struggle to renew themselves effectively.
“Impaired neural stem cell regeneration has long been associated with neurological aging,” explained a senior researcher involved in the study. “Inadequate neural stem cell regeneration inhibits the formation of new cells needed to support learning and memory functions. Understanding the mechanisms for neural stem cell regeneration provides a stronger foundation for studying age-related cognitive decline.”
Potential for Therapies to Slow Brain Aging
The research indicates that strategies aimed at increasing DMTF1 levels or enhancing its activity could potentially reverse or delay the decline in neural stem cell function associated with aging. While the current findings are primarily based on in vitro experiments, the team is already planning further investigations.
Future research will focus on determining whether increasing DMTF1 can boost neural stem cell numbers and improve learning and memory in conditions involving both telomere shortening and natural aging – all while carefully monitoring for potential risks, such as the development of brain tumors. The long-term goal is to identify small molecules capable of safely stimulating DMTF1 activity to rejuvenate aging neural stem cells.
“Our findings suggest that DMTF1 can contribute to neural stem cell multiplication in neurological aging,” stated Dr. Liang. “While our study is in its infancy, the findings provide a framework for understanding how aging-associated molecular changes affect neural stem cell behavior, and may ultimately guide the development of successful therapeutics.”
